Results 101 to 110 of about 4,403,980 (152)
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Ronal Simanjuntak,2 Iwan Dwi Santoso,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, PT Equilab ...
Tjandrawinata RR +5 more
core
Mi-Hong Min,1,2 Jin-Hyong Park,2 Jong-Hyun Hur,2 Ho-Chul Shin,2 YoungJoo Cho,2 Dae-Duk Kim11College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea; 2Central Research Institute ...
Park JH +5 more
core
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Iwan Dwi Santoso,2 Arini Setiawati,3 Liana W Susanto11Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, Equilab ...
Tjandrawinata RR +5 more
core
Bioavailability and Bioequivalence Studies for Chinese Medicines: Challenge and Opportunity
Advanced discussions of the current issues and analyzing the novel approaches of bioavailability & bioequivalence Advanced analytical technologies have provided approaches in analyzing the bioactivities of single component drugs, while the complexity of ...
Feng, Y
core
We show that correct statistical inference from simulated virtual clinical trials requires a Bayesian framework. Simulating frequentist test procedures degrades the prior information contained in the model. We demonstrate the application of a Bayesian workflow to PBPK-simulated virtual bioequivalence trials.
openaire +2 more sources
Bioequivalence assessment: a pharmaceutical industry perspective.
Various aspects of bioequivalence are investigated in this paper. Some aspects dealing with bioequivalence studies conducted either during the development of the drug or after its marketing will be presented and discussed: Bioequivalence of highly ...
Cardot, J M +4 more
core
Mechanism-Based Pharmacokinetic and Pharmacodynamic Modeling. [PDF]
Świerczek A.
europepmc +1 more source
Model-Integrated Bioequivalence (MIBE) in Generic Drug Research: Can We Ease the Bioequivalence Burden? [PDF]
Kollipara S +3 more
europepmc +1 more source
Guiding a Diclofenac Sodium Dual-Release Sustained Formulation Development Through In Vitro-In Vivo Relationship Based on Physiologically Based Pharmacokinetics. [PDF]
Wang Q +7 more
europepmc +1 more source
Bioequivalence, Food-Effect Assessment and Exploratory IVIVC of Two Extended-Release Tamsulosin 0.4 mg Formulations in Healthy Mexican Subjects. [PDF]
Hernández Piña OE +5 more
europepmc +1 more source

